News Boehringer latest to axe Alzheimer's drug Company will trial BI 409306 in schizophrenia instead.
News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros
News BMS settles US off-label marketing case for $19.5m BMS illegally promoted schizophrenia drug, says attorney general
News Lundbeck/Otsuka look for new use of mental health drug Companies want new bipolar disorder use for Abilify Maintena.
News Janssen's quarterly schizophrenia drug approved in EU Company hopes new formulation will improve patient outcomes.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
